During the past decade, Regional One Health conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regional One Health" #1 sponsor was "University of Tennessee" with 6 trials, followed by "BiO2 Medical" with 1 trials sponsored, "CalciMedica, Inc." with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Mitsubishi Tanabe Pharma America Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regional One Health" #1 collaborator was "CardioMed Device Consultants, LLC" with 1 trials as a collaborator, "Intrinsic Imaging, LLC" with 1 trials as a collaborator, "Medline Industries" with 1 trials as a collaborator, "Novella Clinical" with 1 trials as a collaborator and "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Regional One Health" are "Acute Pancreatitis" (1 trials), "Brain Injuries, Traumatic" (1 trials), "Bronchopulmonary Dysplasia" (1 trials), "Burns" (1 trials) and "Chronic Disease" (1 trials). Many other conditions were trialed in "Regional One Health" in a lesser frequency.

Most popular intervention types in "Regional One Health" are "Drug" (5 trials), "Device" (3 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "16S rRNA stool microbiome sequencing." (1 trials), "Acetaminophen" (1 trials), "CM-4620 Injectable Emulsion or CM-4620-IE" (1 trials) and "Dressed with bacitracin and petrolatum gauze" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regional One Health" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Regional One Health". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Regional One Health, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Regional One Health, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".